Join biomodal for a dynamic session led by Donna McDade Walker, PhD, Vice President, Global Marketing and Product Management.
Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all 4 canonical bases to measure multiple modes of biology from a single 5ng DNA sample, in a single experiment, with high accuracy. Identify novel multimodal biomarkers to gain transformative insights into current and future states of disease.
During this Lunch & Learn, we will discuss:
The 6-base genome for understanding tumour biology from liquid biopsy
- Methylation states of enhancers in CRC cfDNA samples provide evidence that 5mC and 5hmC track cancer stage with greater precision.
- 6-base readouts provide two-dimensional methylation data that shows hmC variations that are associated with stage 1 vs healthy
Lunch will be provided. Please register for this event below.
